Meet the Experts

Direct-to-Patient (DTP) Readiness Assessment

Discover Your Product’s DTP Potential

Herspiegel’s Direct-to-Patient (DTP) Readiness Assessment Tool helps biopharma teams evaluate whether DTP can truly create impact for their product and patients.

In just a few minutes, you’ll receive a data-driven readiness score that highlights opportunity areas, strategic gaps, and where DTP can deliver measurable value.

Start the Assessment → 

What Is the DTP Readiness Assessment Tool?

Our DTP Readiness Assessment is a self-guided, fact-based framework designed to clarify if, where, and how your product can succeed in a direct-to-patient model. It distills complex market and patient dynamics into a single readiness signal, helping you make faster, more informed strategic decisions.

A Strategic Tool for Smarter DTP Decisions

The question isn’t whether direct-to-patient (DTP) can raise awareness—it’s whether it will truly move the needle for their product and patients.

The DTP Readiness Assessment Tool translates complex market, access, and behavioral data into a clear readiness signal, helping you:

→ Evaluate your product’s suitability for DTP engagement

→ Assess high-value opportunities and market constraints

→ Focus your launch and access strategy where DTP can deliver the most impact

Some products results will reveal a clear opportunity to scale. Other products may point toward a more focused or phased approach. In every case, the goal remains the same, to give you clarity and confidence in the path ahead.

Why Use the Tool

Developed by Herspiegel, the DTP Readiness Assessment Tool bridges data, strategy, and patient insight to guide commercial decision-making.

It’s designed to help biopharma teams quickly move from exploration to evidence, replacing assumptions with clarity.

  • Strategic, not speculative — Built from real-world patient and market access frameworks

  • Fast but meaningful — Complete in minutes, gain actionable insights instantly

  • Comprehensive lens — Blends access, behavioral, digital, and telehealth considerations

  • Scalable application — Relevant across early planning, launch, and optimization stages

How the Tool Works

Your responses are analyzed across four core DTP Readiness Pillars, each capturing a key dimension of performance potential.

Herspiegel DTP 4 pillars

Each pillar is scored Low / Medium / High and aggregating into a single DTP Readiness Score that reflects your product’s overall opportunity and risk balance.

Assessment Inputs

To ensure accuracy, the tool evaluates ten essential parameters that influence DTP success:

These inputs allow the algorithm to deliver a readiness profile grounded in real-world access, behavioral, and digital market data.

Your Readiness Score

Once complete, the tool instantly generates your personalized DTP Readiness Score.

Your score concisely signals where your product stands today and where strategic refinement could unlock greater value.

The result is not an endpoint but a foundation to:

  • Test different market scenarios and patient behaviors

  • Identify where digital access or behavioral interventions can amplify performance

  • Refine launch and commercialization strategy

For tailored interpretation, Herspiegel experts can help transform your readiness score into a targeted, actionable roadmap.

Ready to See Where Your Product Stands?

Complete the DTP Readiness Assessment to identify your product’s readiness level and key opportunities for improvement.

Then, take the next step—request a consultation by filling out the form below, or follow the link provided after completing the self-assessment to connect with our experts.

Our expert team will help you translate your results into a data-driven roadmap for direct-to-patient success.

Start the Assessment → 

Request a Consultation

Our experts can help interpret your results and turn your readiness score into a focused DTP roadmap.

Meet the Experts:

FAQs for DTP Readiness Assessment

1. What is the DTP Readiness Assessment Tool?

A self-guided diagnostic that evaluates your product’s readiness for direct-to-patient engagement across four key pillars.

2. Who should use this tool?

Commercial, access, and brand teams assessing DTP potential for new or existing therapies.

3. How long does it take?

Approximately 3–5 minutes to complete.

4. How is the score calculated?

Your responses are benchmarked against industry data and weighted across four readiness pillars.

5. What happens after I receive my score?

You can download a results summary and request a consultation to explore implications and next steps with our experts.

The DTP Readiness Assessment is an informational framework designed to support strategic decision-making. It is not intended to provide medical, regulatory, or legal advice. Results and recommendations are indicative and based on user inputs and available market data at the time of assessment. Herspiegel Consulting makes no warranties, express or implied, regarding accuracy, completeness, or future performance. Users should exercise their own professional judgment when interpreting the results and making business or investment decisions.

© 2025. Herspiegel.

Meet the Authors

Let's Talk

Herspiegel is a leading professional services firm helping biotech start-ups and the world’s largest pharmaceutical companies navigate the path from science to brand performance and change patients’ lives. We are committed to using strategic insights from medical to commercial to market access to solve critical problems.